Exscientia Files For $100M IPO
Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design
UK life science attracts £850m deal
Drug discovery platform Exscientia sets terms for $275 million US IPO
ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie
Investment Into Biosciences Boomed, Could The Bubble Burst?
Experts discuss barriers to deep tech ventures
Accenture’s Julie Sweet: A.I. can transform companies, creating ‘responsibility and possibility’ for CEOs
Biotech investors cap off record year in fundraising
Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus
ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding
